Beckley Psytech

About:

Beckley Psytech is a clinical-stage biotechnology company that explores the therapeutic potential of psychedelic substances.

Website: https://www.beckleypsytech.com

Top Investors: Bossanova Investimentos, FJ Labs, What If Ventures, ATAI Life Sciences, Adage Capital Management

Description:

Beckley Psytech operates as a psychedelic medicine company. The company is involved in exploring the therapeutic potential of psychedelic substances, such as psilocybin and other compounds, for mental health treatment. The company envisions the integration of clinically validated psychedelic medicines into contemporary medical practices to assist individuals coping with depression and other significantly debilitating neuropsychiatric conditions characterized by a substantial unmet need.

Total Funding Amount:

$164M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Beckley, Oxfordshire, United Kingdom

Founded Date:

2019-01-01

Founders:

Cosmo Feilding Mellen, Lady Amanda Feilding

Number of Employees:

11-50

Last Funding Date:

2024-01-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai